Cargando…
Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension
Hypertension is particularly prevalent in patients aged ⩾65 years, those with a body mass index ⩾30 kg m(−2), Blacks and those with type II diabetes. Here we report a prespecified secondary analysis of the efficacy of amlodipine (10 mg day(−1)), olmesartan medoxomil (40 mg day(−1)), a combination of...
| Autores principales: | , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963900/ https://www.ncbi.nlm.nih.gov/pubmed/20164847 http://dx.doi.org/10.1038/jhh.2010.5 |